Diversified Enterprises’s Vertex Pharmaceuticals VRTX Stock Holding History

Diversified Enterprises’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$632K	Buy	1,208 +335	+38%	+$172K	0.03%	239
2026 Q2	$434K	Sell	873 -559	-39%	-$248K	0.02%	267
2026 Q1	$639K	Sell	1,432 -175	-11%	-$81.6K	0.04%	207
2025 Q4	$729K	Buy	+1,607	New	+$693K	0.04%	166
2025 Q3	–	Sell	-505	Closed	-$225K	–	334
2025 Q2	$225K	Sell	505 -42	-8%	-$19.4K	0.02%	288
2025 Q1	$265K	Buy	+547	New	+$255K	0.02%	250

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Diversified Enterprises's VRTX Position: Q3 2026 in Review

Diversified Enterprises increased its Vertex Pharmaceuticals (VRTX) stake by 38% in Q3 2026, buying an estimated $172K and bringing the position to 1,208 shares worth $632K. The position accounts for 0.03% of the portfolio, ranked #239.

Diversified Enterprises first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $729K in Q4 2025. 700 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Diversified Enterprises held 1,208 shares of Vertex Pharmaceuticals worth $632K as of Q3 2026.
Diversified Enterprises bought 335 Vertex Pharmaceuticals shares in Q3 2026, an estimated $172K.
Vertex Pharmaceuticals made up 0.03% of Diversified Enterprises's portfolio in Q3 2026, its #239 holding.
Diversified Enterprises first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Diversified Enterprises's Vertex Pharmaceuticals position peaked at $729K in Q4 2025.
700 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Diversified Enterprises's 13F filing for Q3 2026, filed 19 Oct 2026.